NUWE
- Nuwellis, Inc.
()
Overview
Company Summary
Nuwellis, Inc. (formerly known as CHF Solutions, Inc.) is a medical device company that specializes in developing innovative solutions for the management of fluid overload in patients suffering from congestive heart failure (CHF) and other similar conditions. Fluid overload is a condition where excessive fluid accumulates in the body, causing symptoms such as shortness of breath, swelling, and weight gain.
Nuwellis developed a unique medical device called the Aquadex FlexFlow System, which is designed to effectively remove excess fluid from patients suffering from fluid overload. The system uses a gentle, adjustable, and precise method called ultrafiltration to extract fluid from the patient's blood, removing the burden from the heart and kidneys.
The Aquadex FlexFlow System consists of a console, fluid balance monitoring technology, and a disposable blood circuit. It is primarily used in hospitals and other clinical settings, where medical professionals can safely and efficiently manage the fluid levels of patients with fluid overload.
By providing a clinically proven alternative to traditional diuretic therapy, the Aquadex FlexFlow System enables healthcare professionals to achieve better fluid management outcomes for patients with fluid overload. This can lead to improved relief of symptoms, reduced hospitalization durations, fewer readmissions, and an overall improvement in the quality of life for patients suffering from CHF and related conditions.
In summary, Nuwellis, Inc. is a medical device company that focuses on developing and commercializing the Aquadex FlexFlow System, a unique solution for the management of fluid overload in patients with congestive heart failure and similar conditions.